Page results
-
The Acute Stroke Unit (ASU) is the next step of care for stroke patients who come to the Hyper-acute Stroke Unit (HASU) at UCLH.
-
Our Brain Tumour Service is a pioneering specialist centre offering high-quality treatment and care to patients with all forms of brain or spinal tumours.
-
The movement disorders group specialises in the assessment, diagnosis and treatment of people with diseases such as Parkinson’s disease, dystonia, tremor, myoclonus and chorea.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
Skeletal uscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
Autoimmune serology is provided for: Connective tissue diseases, Endocrine diseases, Liver diseases, Rheumatic diseases, Skin diseases, Thyroid diseases.
-
The Pathogen Genomic Unit offers access to explore the clinical applications and interpretation of pathogen genomic data for patients with a variety of infections.
-
This clinic is for asymptomatic travellers (individuals with no current symptoms) who have travelled to a tropical destination and are worried about certain infections.
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements